Degron Therapeutics logo

Degron Therapeutics

Aims to become a global leader in the discovery and development of molecular glue degraders

25 employees · est. 2021 · San Diego, United States

VS
Owl Therapeutics logo

Owl Therapeutics

Unlocking Wisdom for Brain Health

2 employees · est. 2023 · San Antonio, United States

Degron Therapeutics is the older company (2021 vs 2023); Degron Therapeutics is the larger of the two.

Side-by-Side Comparison

Degron Therapeutics Owl Therapeutics
Founded
2021 older 2023
Headquarters
San Diego, United States San Antonio, United States
Employees
25 larger 2
Industry
Biotechnology, Health Care Biopharma
Funding Stage
Series A Not tracked yet
Total Funding
$82.00M Not tracked yet
Funding Rounds
6 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biotech, Drug Discovery, Molecular Glue Degraders, Small Molecule Inhibitors, Targeted Protein Degradation, Therapeutics, Scientific Excellence, Oncology, Inflammation, Metabolic Diseases, Medical Innovation, Pharmaceutical Research, Disease Targets, Global Leader, Unmet Medical Needs Owl Therapeutics, Gryphon Bio, Biopharmaceutical Company, Clinical-stage, Therapeutics, Traumatic Brain Injury, Neurodegenerative Disease, Drug Development, Diagnostics, Brain Health
Website
degrontx.com owltherapeutics.com
Degron Therapeutics logo

About Degron Therapeutics

Degron Therapeutics is a biotechnology startup founded in 2021 in the United States. The company's slogan "Aims to become a global leader in the discovery and development of molecular glue degraders" highlights its ambition in the industry. Degron Therapeutics is focused on pioneering a new class...

Owl Therapeutics logo

About Owl Therapeutics

Owl Therapeutics is a wholly-owned subsidiary of Gryphon Bio​ that is dedicated to unlocking wisdom for brain health. Specializing in the development of diagnostic-powered therapeutics for traumatic brain injury (TBI) and brain health, Owl Therapeutics has rapidly constructed a diversified pipeline...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Degron Therapeutics and Owl Therapeutics — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Degron Therapeutics and Owl Therapeutics — by email.

Frequently Asked Questions

Degron Therapeutics — Aims to become a global leader in the discovery and development of molecular glue degraders. Owl Therapeutics — Unlocking Wisdom for Brain Health. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Degron Therapeutics has raised $82.00M while Owl Therapeutics has raised undisclosed funding.
Degron Therapeutics and Owl Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Degron Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy